A detailed history of British Columbia Investment Management Corp transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, British Columbia Investment Management Corp holds 115,167 shares of EW stock, worth $7.54 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
115,167
Previous 72,640 58.54%
Holding current value
$7.54 Million
Previous $6.94 Million 53.25%
% of portfolio
0.07%
Previous 0.05%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$84.3 - $94.31 $3.59 Million - $4.01 Million
42,527 Added 58.54%
115,167 $10.6 Million
Q1 2024

May 14, 2024

BUY
$72.54 - $95.56 $193,681 - $255,145
2,670 Added 3.82%
72,640 $6.94 Million
Q4 2023

Feb 14, 2024

BUY
$61.71 - $77.76 $914,171 - $1.15 Million
14,814 Added 26.86%
69,970 $5.34 Million
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $33,462 - $45,102
483 Added 0.88%
55,156 $3.82 Million
Q2 2023

Aug 11, 2023

SELL
$81.41 - $94.33 $40,460 - $46,882
-497 Reduced 0.9%
54,673 $5.16 Million
Q1 2023

May 12, 2023

BUY
$74.26 - $84.51 $18,267 - $20,789
246 Added 0.45%
55,170 $4.56 Million
Q4 2022

Feb 10, 2023

SELL
$68.3 - $87.44 $456,585 - $584,536
-6,685 Reduced 10.85%
54,924 $4.1 Million
Q3 2022

Nov 10, 2022

SELL
$82.37 - $107.29 $890,831 - $1.16 Million
-10,815 Reduced 14.93%
61,609 $5.09 Million
Q2 2022

Aug 12, 2022

SELL
$86.5 - $128.27 $2.07 Million - $3.07 Million
-23,961 Reduced 24.86%
72,424 $6.89 Million
Q1 2022

May 12, 2022

SELL
$101.96 - $128.34 $1.34 Million - $1.68 Million
-13,105 Reduced 11.97%
96,385 $11.3 Million
Q4 2021

Feb 11, 2022

SELL
$106.37 - $130.68 $586,524 - $720,569
-5,514 Reduced 4.79%
109,490 $14.2 Million
Q3 2021

Nov 12, 2021

SELL
$102.91 - $122.75 $68,332 - $81,506
-664 Reduced 0.57%
115,004 $13 Million
Q2 2021

Aug 09, 2021

SELL
$83.84 - $104.76 $18.9 Million - $23.6 Million
-225,509 Reduced 66.1%
115,668 $12 Million
Q1 2021

Apr 30, 2021

BUY
$78.68 - $90.67 $1.55 Million - $1.79 Million
19,695 Added 6.13%
341,177 $28.5 Million
Q4 2020

Feb 02, 2021

BUY
$71.69 - $91.23 $1.91 Million - $2.43 Million
26,687 Added 9.05%
321,482 $29.3 Million
Q3 2020

Nov 10, 2020

BUY
$67.19 - $87.44 $2.78 Million - $3.62 Million
41,347 Added 16.31%
294,795 $23.5 Million
Q2 2020

Aug 12, 2020

BUY
$57.54 - $76.95 $13.3 Million - $17.7 Million
230,633 Added 1010.88%
253,448 $17.5 Million
Q1 2020

May 13, 2020

SELL
$52.41 - $81.0 $1.38 Million - $2.13 Million
-26,259 Reduced 53.51%
22,815 $4.3 Million
Q4 2019

Feb 12, 2020

SELL
$71.7 - $82.09 $2.57 Million - $2.94 Million
-35,824 Reduced 42.2%
49,074 $11.4 Million
Q3 2019

Nov 14, 2019

SELL
$61.55 - $75.43 $377,547 - $462,687
-6,134 Reduced 6.74%
84,898 $18.7 Million
Q2 2019

Aug 12, 2019

BUY
$55.74 - $64.41 $1.88 Million - $2.17 Million
33,716 Added 58.82%
91,032 $16.8 Million
Q1 2019

May 08, 2019

SELL
$47.89 - $64.05 $1.1 Million - $1.47 Million
-22,960 Reduced 28.6%
57,316 $11 Million
Q4 2018

Feb 13, 2019

SELL
$46.41 - $56.94 $1.31 Million - $1.6 Million
-28,140 Reduced 25.96%
80,276 $12.3 Million
Q3 2018

Nov 13, 2018

SELL
$45.7 - $58.03 $970,119 - $1.23 Million
-21,228 Reduced 16.37%
108,416 $18.9 Million
Q2 2018

Aug 09, 2018

SELL
$42.45 - $51.3 $1.75 Million - $2.12 Million
-41,235 Reduced 24.13%
129,644 $18.9 Million
Q1 2018

May 15, 2018

SELL
$37.19 - $47.45 $783,444 - $999,581
-21,066 Reduced 10.98%
170,879 $23.8 Million
Q4 2017

Feb 20, 2018

BUY
$33.79 - $39.39 $680,902 - $793,747
20,151 Added 11.73%
191,945 $21.6 Million
Q3 2017

Nov 14, 2017

BUY
$36.29 - $38.83 $6.23 Million - $6.67 Million
171,794
171,794 $18.8 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track British Columbia Investment Management Corp Portfolio

Follow British Columbia Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.